Mutations in the IFNγ-JAK-STAT Pathway Causing Resistance to Immune Checkpoint Inhibitors in Melanoma Increase Sensitivity to Oncolytic Virus Treatment.

MLA

Nguyen, Tan-Trieu, et al. “Mutations in the IFNγ-JAK-STAT Pathway Causing Resistance to Immune Checkpoint Inhibitors in Melanoma Increase Sensitivity to Oncolytic Virus Treatment.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 27, no. 12, June 2021, pp. 3432–42. EBSCOhost, https://doi.org/10.1158/1078-0432.CCR-20-3365.

APA

Nguyen, T.-T., Ramsay, L., Ahanfeshar-Adams, M., Lajoie, M., Schadendorf, D., Alain, T., & Watson, I. R. (2021). Mutations in the IFNγ-JAK-STAT Pathway Causing Resistance to Immune Checkpoint Inhibitors in Melanoma Increase Sensitivity to Oncolytic Virus Treatment. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 27(12), 3432–3442. https://doi.org/10.1158/1078-0432.CCR-20-3365

Chicago

Nguyen, Tan-Trieu, LeeAnn Ramsay, Mozhdeh Ahanfeshar-Adams, Mathieu Lajoie, Dirk Schadendorf, Tommy Alain, and Ian R Watson. 2021. “Mutations in the IFNγ-JAK-STAT Pathway Causing Resistance to Immune Checkpoint Inhibitors in Melanoma Increase Sensitivity to Oncolytic Virus Treatment.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 27 (12): 3432–42. doi:10.1158/1078-0432.CCR-20-3365.